Obstructive pulmonary disease in rheumatoid arthritis.

Area of Science:

• Pulmonary Medicine
• Rheumatology
• Genetics

Background:

• Rheumatoid arthritis (RA) is a systemic autoimmune disease.
• Pulmonary complications are common in RA patients.
• Obstructive pulmonary disease (OPD) can affect RA patients.

Purpose of the Study:

• To investigate the prevalence of obstructive pulmonary disease in rheumatoid arthritis patients.
• To identify risk factors associated with airway obstruction in RA.

Main Methods:

• Prospective, controlled study.
• Assessed maximal midexpiratory flow rates (MMEFs) in 43 RA patients.
• Compared MMEFs between RA patients (smokers and non-smokers) and smokers with degenerative joint disease.

Main Results:

• 60.5% of RA patients exhibited MMEFs indicative of obstructive pulmonary disease.
• RA patients who smoked had significantly lower MMEFs compared to non-smokers with RA or smokers with degenerative joint disease.
• Increased prevalence of Pi phenotype MS was observed in RA patients.
• Interstitial fibrosis, tobacco smoking, and protease inhibitor deficiencies were significant contributors to airway obstruction in RA.

Conclusions:

• Obstructive pulmonary disease is prevalent in rheumatoid arthritis patients.
• Tobacco smoking and genetic factors (protease inhibitor deficiencies) exacerbate airway obstruction in RA.
• Further research is warranted to understand and manage pulmonary manifestations in RA.